Effect of the diabetes outpatient intensive management programme on glycaemic control for type 2 diabetic patients
Article first published online: 19 JUN 2007
Journal of Clinical Nursing
Volume 16, Issue 7, pages 1367–1373, July 2007
How to Cite
Song, M.-S. and Kim, H.-S. (2007), Effect of the diabetes outpatient intensive management programme on glycaemic control for type 2 diabetic patients. Journal of Clinical Nursing, 16: 1367–1373. doi: 10.1111/j.1365-2702.2007.01800.x
- Issue published online: 19 JUN 2007
- Article first published online: 19 JUN 2007
- Submitted for publication: 31 January 2006 Accepted for publication: 20 June 2006
- glycosylated haemoglobin;
- type 2 diabetes
Aim. The purpose of this study was to examine the effect of the diabetes outpatient intensive management programme (DOIMP) on glycaemic control over a 12 week follow-up period for type 2 diabetic patients in Korea.
Background. Diabetic complications can be prevented if the glycaemic status of diabetes patients is maintained within a nearly normal range. Patient education is critical in controlling blood glucose levels of patients with diabetes within the optimal range.
Methods. DOIMP was composed of multidisciplinary education, complication monitoring and telephone counselling. Twenty-five patients in the intervention group participated in the DOIMP and 24 patients in the control group were briefed on the conventional description of diabetes mellitus by diabetes education nurses.
Results. Patients in the intervention group had a mean decrease of 2·3%, which those in the control group having a mean decrease 0·4% in glycosylated haemoglobin (HbA1c). There was no difference between the two groups in the change in fasting blood glucose (FBG) and two-hour postprandial blood glucose (2-h PBG). The proportion of the patients with HbA1c <7% was higher in the intervention group than in the control group at the post-test compare with the pretest.
Conclusion. DOIMP can reduce HbA1c in type 2 diabetes patients.
Relevance to clinical practice. These findings indicated that DOIMP could be effective in glycaemic control in type 2 diabetes patients.